Exec Director
Gilead Sciences, Inc.
Foster City, California, United States
Toxicological Assessment of Pharmaceutical Impurities (CE8)
Sunday, November 17, 2024
1:00 PM - 4:30 PM CT
ICH M7: Identification and Control of Mutagenic Impurities in Pharmaceuticals (CE8-4)
Sunday, November 17, 2024
3:00 PM - 3:30 PM CT
Managing Nonmutagenic Impurities in Pharmaceuticals: Emerging Science (S13)
Tuesday, November 19, 2024
2:00 PM - 5:00 PM CT
Overview of Impurity Qualification and How is it Used by Chemistry? (S13-2)
Tuesday, November 19, 2024
2:05 PM - 2:30 PM CT